Strand bias in oligonucleotide-mediated dystrophin gene editing

Human Molecular Genetics

Volumn 14, Issue 2, 2005, Pages 221-233

  Bertoni, Carmen ^a   Morris, Glenn E ^b   Rando, Thomas A ^a,c  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GLYNDWR UNIVERSITY   (United Kingdom)

^c VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DYSTROPHIN; GENOMIC DNA; MESSENGER RNA; OLIGODEOXYNUCLEOTIDE DERIVATIVE; OLIGONUCLEOTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BASE PAIRING; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE MODEL; DNA REPAIR; DNA STRAND; DNA VECTOR; DUCHENNE MUSCULAR DYSTROPHY; GENE SEQUENCE; GENE TARGETING; GENETIC TRANSCRIPTION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; MOUSE STRAIN; MUSCLE CELL; MYOBLAST; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; RNA EDITING; RNA VECTOR;

ANIMALS; BASE SEQUENCE; DYSTROPHIN; GENE TRANSFER TECHNIQUES; IN SITU HYBRIDIZATION, FLUORESCENCE; MICE; MICE, INBRED MDX; MOLECULAR SEQUENCE DATA; MUSCLE CELLS; MUSCULAR DYSTROPHY, DUCHENNE; MUTATION; RNA, MESSENGER; SEQUENCE ANALYSIS, DNA;

EID: 12744274779     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/ddi020     Document Type: Article

References (39)

1. Koenig, M., Hoffman, E.P., Bertelson, C.J., Monaco, A.P., Feener, C. and Kunkel, L.M. (1987) Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell, 50, 509-517.
2. Amalfitano, A., Rafael, J.A. and Chamberlain, J.S. (1996) Structure and mutation of the dystrophin gene. In Brown, S.C. and Lucy, J.A. (eds.), Dystrophin. Cambridge University Press, Cambridge, pp. 1-26.
3. Gregorevic, P. and Chamberlain, J.S. (2003) Gene therapy for muscular dystrophy - a review of promising progress. Expert. Opin. Biol. Ther., 3, 803-814.
4. Rando, T.A. (2002) Oligonucleotide-mediated gene therapy for muscular dystrophies. Neuromuscul. Disord., 12, S55-S60.
5. van Deutekom, J.C., Bremmer-Bout, M., Janson, A.A., Ginjaar, I.B., Baas, F., den Dunnen, J.T. and van Ommen, G.J. (2001) Antisense-induced exon skipping restores dystrophin expression in DMD patient derived muscle cells. Hum. Mol. Genet., 10, 1547-1554.
6. Lu, Q.L., Mann, C.J., Lou, F., Bou-Gharios, G., Morris, G.E., Xue, S.A., Fletcher, S., Partridge, T.A. and Wilton, S.D. (2003) Functional amounts of dystrophin produced by skipping the mutated exon in the mdx dystrophic mouse. Nat. Med., 9, 1009-1014.
7. Rando, T.A., Disatnik, M.H. and Zhou, L.Z. (2000) Rescue of dystrophin expression in mdx mouse muscle by RNA/DNA oligonucleotides. Proc. Natl Acad. Sci. U.S.A, 97, 5363-5368.
8. Bertoni, C. and Rando, T.A. (2002) Dystrophin gene repair in mdx muscle precursor cells in vitro and in vivo mediated by RNA-DNA chimeric oligonucleotides. Hum. Gene Ther., 13, 707-718.
9. Bertoni, C., Lau, C. and Rando, T.A. (2003) Restoration of dystrophin expression in mdx muscle cells by chimeraplast-mediated exon skipping. Hum. Mol. Genet., 12, 1087-1099.
10. Yoon, K., Cole-Strauss, A. and Kmiec, E.B. (1996) Targeted gene correction of episomal DNA in mammalian cells mediated by a chimeric RNA/DNA oligonucleotide. Proc. Natl. Acad. Sci. U.S.A, 93, 2071-2076.
11. Cole-Strauss, A., Yoon, K., Xiang, Y., Byrne, B.C., Rice, M.C., Gryn, J., Holloman, W.K. and Kmiec, E.B. (1996) Correction of the mutation responsible for sickle cell anemia by an RNA-DNA oligonucleotide. Science, 273, 1386-1389.
12. Kren, B.T., Bandyopadhyay, P. and Steer, C.J. (1998) In vivo site-directed mutagenesis of the factor IX gene by chimeric RNA/DNA oligonucleotides. Nat. Med., 4, 285-290.
13. Tagalakis, A.D., Graham, I.R., Riddell, D.R., Dickson, J.G. and Owen, J.S. (2001) Gene correction of the apolipoprotein (Apo) E2 phenotype to wild-type ApoE3 by in situ chimeraplasty. J. Biol. Chem., 276, 13226-13230.
14. Alexeev, V., Igoucheva, O., Domashenko, A., Cotsarelis, G. and Yoon, K. (2000) Localized in vivo genotypic and phenotypic correction of the albino mutation in skin by RNA-DNA oligonucleotide. Nat. Biotechnol., 18, 43-47.
15. Rice, M.C., Czymmek, K. and Kmiec, E.B. (2001) The potential of nucleic acid repair in functional genomics. Nat. Biotechnol., 19, 321-326.
16. Gamper, H.B., Parekh, H., Rice, M.C., Bruner, M., Youkey, H. and Kmiec, E.B. (2000) The DNA strand of chimeric RNA/DNA oligonucleotides can direct gene repair/conversion activity in mammalian and plant cell-free extracts. Nucleic Acids Res., 28, 4332-4339.
17. Igoucheva, O., Alexeev, V. and Yoon, K. (2001) Targeted gene correction by small single-stranded oligonucleotides in mammalian cells. Gene Ther., 8, 391-399.
18. Liu, L., Rice, M.C. and Kmiec, E.B. (2001) In vivo gene repair of point and frameshift mutations directed by chimeric RNA/DNA oligonucleotides and modified single-stranded oligonucleotides. Nucleic Acids Res., 29, 4238-4250.
19. Alexeev, V., Igoucheva, O. and Yoon, K. (2002) Simultaneous targeted alteration of the tyrosinase and c-kit genes by single-stranded oligonucleotides. Gene Ther., 9, 1667-1675.
20. Igoucheva, O., Alexeev, V., Pryce, M. and Yoon, K. (2003) Transcription affects formation and processing of intermediates in oligonucleotide-mediated gene alteration. Nucleic Acids Res., 31 2659-2670.
21. Pierce, E.A., Liu, Q., Igoucheva, O., Omarrudin, R., Ma, H., Diamond, S.L. and Yoon, K. (2003) Oligonucleotide-directed single-base DNA alterations in mouse embryonic stem cells. Gene Ther., 10 24-33.
22. Igoucheva, O., Alexeev, V. and Yoon, K. (2004) Oligonucleotide-directed mutagenesis and targeted gene correction: a mechanistic point of view. Curr. Mol. Med., 4, 445-463.
23. Lu, I.L., Lin, C.Y., Lin, S.B., Chen, S.T., Yeh, L.Y., Yang, F.Y. and Au, L.C. (2003) Correction/mutation of acid alpha-D-glucosidase gene by modified single-stranded oligonucleotides: in vitro and in vivo studies. Gene Ther., 10, 1910-1916.
24. Nickerson, H.D. and Colledge, W.H. (2003) A comparison of gene repair strategies in cell culture using a lacZ reporter system. Gene Ther., 10, 1584-1591.
25. Bennett, M. and Schaack, J. (2003) Development of a dual-luciferase fusion gene as a sensitive marker for site-directed DNA repair strategies. J. Gene Med., 5, 723-732.
26. Dekker, M., Brouwers, C. and te Riele, H. (2003) Targeted gene modification in mismatch-repair-deficient embryonic stem cells by single-stranded DNA oligonucleotides. Nucleic Acids Res., 31, e27.
27. Brachman, E.E. and Kmiec, E.B. (2003) Targeted nucleotide repair of CYC1 mutations in Saccharomyces cerevisiae directed by modified single-stranded DNA oligonucleotides. Genetics, 163, 527-538.
28. Im, W.B., Phelps, S.F., Copen, E.H., Adams, E.G., Slightom, J.L. and Chamberlain, J.S. (1996) Differential expression of dystrophin isoforms in strains of mdx mice with different mutations. Hum. Mol. Genet., 5, 1149-1153.
29. Emery, A.E.H. (1993) Duchenne Muscular Dystrophy. Oxford University Press, New York.
30. Lu, Q.L., Morris, G.E., Wilton, S.D., Ly, T., Artem'yeva, O.V., Strong, P. and Partridge, T.A. (2000) Massive idiosyncratic exon skipping corrects the nonsense mutation in dystrophic mouse muscle and produces functional revertant fibers by clonal expansion. J. Cell Biol., 148, 985-996.
31. Danko, I., Chapman, V. and Wolff, J.A. (1992) The frequency of revertants in mdx mouse genetic models for Duchenne muscular dystrophy. Pediatr. Res., 32, 128-131.
32. Zhang, Z., Eriksson, M., Falk, G., Graff, C., Presnell, S.C., Read, M.S., Nichols, T.C., Blomback, M. and Anvret, M. (1998) Failure to achieve gene conversion with chimeric circular oligonucleotides: potentially misleading PCR artifacts observed. Antisense Nucleic Acid Drug Dev., 8, 531-536.
33. Andersen, M.S., Sorensen, C.B., Bolund, L. and Jensen, T.G. (2002) Mechanisms underlying targeted gene correction using chimeric RNA/DNA and single-stranded DNA oligonucleotides. J. Mol. Med., 80, 770-781.
34. Liu, L., Rice, M.C., Drury, M., Cheng, S., Gamper, H. and Kmiec, E.B. (2002) Strand bias in targeted gene repair is influenced by transcriptional activity. Mol. Cell Biol., 22, 3852-3863.
35. Phelps, S.F., Hauser, M.A., Cole, N.M., Rafael, J.A., Hinkle, R.T., Faulkner, J.A. and Chamberlain, J.S. (1995) Expression of full-length and truncated dystrophin mini-genes in transgenic mdx mice. Hum. Mol. Genet., 4, 1251-1258.
36. Hendrich, B., Hardeland, U., Ng, H.H., Jiricny, J. and Bird, A. (1999) The thymine glycosylase MBD4 can bind to the product of deamination at methylated CpG sites. Nature, 401, 301-304.
37. Rando, T.A., Disatnik, M.H., Yu, Y. and Franco, A. (1998) Muscle cells from mdx mice have an increased susceptibility to oxidative stress. Neuromuscul. Disord., 8, 14-21.
38. Bartlett, R.J., Stockinger, S., Denis, M.M., Bartlett, W.T., Inverardi, L., Le, T.T., thi Man, N., Morris, G.E., Bogan, D.J., Metcalf-Bogan, J. and Kornegay, J.N. (2000) In vivo targeted repair of a point mutation in the canine dystrophin gene by a chimeric RNA/DNA oligonucleotide. Nat. Biotechnol., 18, 615-622.
39. Lu, Q.L. and Partridge, T.A. (1998) A new blocking method for application of murine monoclonal antibody to mouse tissue sections. J. Histochem. Cytochem., 46, 977-984.